Imakethe Yezokwelapha KaHuntington usayizi wenziwa inani I-USD 325 million ngo-2021, Kuya I-USD 1813.18 million ngo-2030, ekhombisa a I-CAGR ye-19.5% phakathi kuka-2022-2030.

Esikhathini sokubikezela, ingxenye ekhula ngokushesha emakethe yezokwelapha ezishintsha izifo kulindeleke ukuthi kube iyona ekhula kakhulu. Lokhu kungenxa yokwenyuka kwe-R&D ekwelashweni kokuguqula izifo kanye nesidingo esikhulayo semikhiqizo ethuthukisiwe njengokwelashwa ngofuzo noma ukwelapha nge-stem cell. Ngokuzayo, imakethe ingase igqugquzelwe izinhlelo zikahulumeni ezivumayo ezifana ne-Fast Track Designation (US FDA), esheshisa inqubo yokubhalisa. Umuthi we-Sage Therapeutics i-SAGE-718 wanikezwa igama elisheshayo yi-US FDA ngoSepthemba 2021 njengokwelashwa okungenzeka kwe-Huntington's Disease.

Ungacela Inguqulo Yedemo Yombiko Ngaphambi Kokuthenga Lapha:  https://market.us/report/huntington-s-disease-treatment-market/request-sample/

I-Huntington's Disease Treatment Market: Abashayeli

Ukwenyuswa Kwemithi Yokwelapha Ethuthukisiwe kanye Nemithi Ukuze Kuqhutshwe Isidingo Sezinketho Zokwelashwa.

Ukwandiswa kwemakethe kuzoqhutshwa ukubandakanyeka kwabadlali ababalulekile bemboni ekufuneni ukwelashwa kwe-Huntington's Disease (HD). Lokhu kungase kube ngenxa yokwanda kwezibalo zeziguli kanye nokusabalala kwezifo eYurophu naseNyakatho Melika. Ukukhula kwemakethe kuzosizwa isidingo esingafinyeleleki sezidakamizwa ezishintsha i-HD nokwelapha.

Ukwandisa Ucwaningo Nentuthuko ukuze Kusheshiswe Ukuthuthukiswa Kwemakethe.

Isifo sikaHuntington aselapheki. Akukho ukwelashwa noma ukwelashwa. Lokhu kusho ukuthi maningi amathuba okucwaninga nokuthuthukisa izindlela ezintsha zokwelapha. Lokhu kuzothuthukisa ukukhula kwemakethe kakhulu esikhathini sokubikezela. Izinhlelo zikahulumeni ezingaba khona ezikhuthaza ukuthuthukiswa kwemithi emisha kuzoba esinye isici esiqhuba ukwanda kwemakethe.

Imakethe yokwelashwa kwezifo kaHuntington: Imikhawulo

Ukushoda kwezidakamizwa kuphazamisa ukukhula kwemakethe.

Isifo sika-Huntington sinenani elilinganiselwe lemithi elayisensi ngenxa yamazinga aqinile nemikhawulo. Lokhu kuzonciphisa ukukhula kwemakethe phakathi naso sonke isikhathi sokubikezela. Ngenxa yenhlamba ehambisana nesifo sika-Huntington, ukuqwashisa okuphansi ezingxenyeni eziningi zomhlaba, imikhawulo eqinile yokugunyazwa kwezidakamizwa, izinhlelo ezihlukile zokwelapha, kanye nenani elincane lemithi egunyaziwe cishe kuzokhawulela ukukhula kwemakethe.

Amathrendi Abalulekile Emakethe:

I-Huntington's Disease Treatment Market kulindeleke ukuthi ibe nesabelo semakethe esibalulekile se-Symptomatic Treatment Segment.

Isabelo esikhulu kunazo zonke kulindeleke ukuthi sibanjwe ingxenye yokwelashwa okuyizimpawu phakathi noNyaka wokubikezela. Imali engenayo yesegimenti ikhuliswe ukutholakala okuphezulu kanye nesilinganiso sokusetshenziswa kokwelashwa kokulawulwa kwezimpawu. Lesi sigaba sikhiqiza imali ephezulu ngenxa yesidingo sokwelashwa okuningi kanye nokungenelela kwethimba lezisebenzi ezinolwazi oluningi.

Ukukhubazeka kwezimoto kanye ne-chorea yikona okugxilwe kakhulu ekuthuthukisweni kokwelashwa okunezimpawu. I-Chorea iseyisici somtholampilo esivame kakhulu sesifo sikaHuntington. Ucwaningo oluningi lwezokwelapha luye lwenziwa kuso. Ngokwesibonelo, i-Neurocrine Biosciences, imemezele ukuthi i-valentine yehlise kakhulu i-chorea ezigulini zika-Huntington ocwaningweni lomtholampilo lweSigaba 3 olubizwa ngokuthi-KINECT HD ngoDisemba 2021. Iphepha locwaningo langoMeyi 2021 elishicilelwe ku-Brain labonisa ukuthi ukwelapha ukuhlela izakhi zofuzo kungase kubambezele ukuqhubeka kwezimpawu. Lezi zifundo eziqhubekayo zizodlala indima ebalulekile ekunqumeni isabelo semakethe sale ngxenye eminyakeni ezayo.

Ukuthuthukiswa kwakamuva:

I-Ionis Pharmaceuticals, Inc. yamemezela ngoJanuwari 2022 ukusebenzisana ne-Roche ukuze kuhlolwe i-tominersen ovivinyweni lweSigaba 2 sokwelashwa kweSifo sika-Huntington.

U-Novartis, umkhiqizi ohamba phambili wezindlela zokwelapha eziguqula izifo zesifo sika-Huntington, umemezele ukuthi uNovartis unikezwe isikhundla se-FDA Fast Track ngoDisemba 2021.

Umhlaba Oncintisanayo:

• I-Valeant Pharmaceuticals
• I-Teva Pharmaceuticals
• I-Wave Life Sciences
• Ionis Pharmaceuticals/ Roche
• I-Raptor Pharmaceuticals
• I-Prana Biotechnology

Uhlobo

• I-Symptomatic Therapy
• Ukwelashwa Kokuguqula Izifo

Isicelo

• Izibhedlela
• Izikhungo Zokuhlinzwa Zokugibela

Imboni, Ngesifunda

• I-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• IYurophu [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• INyakatho Melika [United States, Canada, Mexico]
• Middle East & Africa [GCC, North Africa, South Africa]
• INingizimu Melika [Brazil, Argentina, Columbia, Chile, Peru]

Imibuzo ebalulekile:

1. Ungakanani usayizi wemakethe wokwelapha isifo sika-Huntington okhula kuwo?
2. Obani ababambiqhaza abakhulu emakethe yokwelapha isifo sikaHuntington?
3. Ingakanani intengo yemakethe elindelwe yokwelapha ukugula kuka-Huntington ngo-2031?
4. Iyiphi indawo etshale imali eningi emakethe yokwelapha isifo sika-Huntington?
5. Obani ababambiqhaza abakhulu emakethe yokwelapha isifo sikaHuntington?
6. Yiziphi izinto eziguquguqukayo ezithonya imakethe yokwelashwa kwesifo sikaHuntington?
7. Iyiphi i-CAGR eyakhulela kuyo imakethe yokwelashwa kwesifo sikaHuntington phakathi kuka-2015 no-2021?
8. Yiziphi izinguquko eziyinhloko esidingweni sabathengi njengoba umnotho ushintsha?
9. Yibuphi ubunzima ama-SME nabahlinzeki abaziwayo ababhekana nabo emakethe yokwelapha isifo sika-Huntington?

Imibiko Ehlobene Eminye Evela Kusayithi lethu le-Market.us:

Usayizi Wemakethe Yokwelashwa Kwezifo Zomhlaba Wonke bekufanelekile I-USD 1.9 billion ngo-2021 futhi kubikezelwa ukuthi kuzoba ne-a 17.9% I-CAGR phakathi kuka-2023-2032.

Imakethe Yokwelapha Izinhlungu Ezingapheli kulindeleke ukuthi kuzuze ukulinganisa kwe I-USD 173.53 Bn ngo-2031 ku-CAGR ye 7.2%, kusukela I-USD 86.58 Bn ngo-2021.'

Imakethe Yokwelapha Izinsumpa Zangasese kulindeleke ukuthi ifinyelele esilinganisweni se $2.16 Ibhiliyoni ngo-2032 ku-CAGR ye 4.8%, kusukela USD I-1.63 Billion e 2021.

I-Global Acne Scar Treatment Market kulindeleke ukuthi ifinyelele esilinganisweni se I-USD 82.59 Bn ngo-2032 a I-CAGR of 13.85%, kusukela I-USD 27.32 Bn e 2022.

Imakethe yomhlaba wonke yokwelapha i-acromegaly yaziswa USD 1,497 wezigidi ngo-2021. Kubikezelwa ukuthi izokhula 7.55% esikhathini sokubikezela.

Mayelana ne-Market.us

I-Market.US (Inikwe amandla yi-Prudour Private Limited) igxile ocwaningweni olujulile lwemakethe nokuhlaziya futhi ibilokhu ifakazela ukuqina kwayo njengenkampani yokubonisana neyenziwe ngendlela oyifisayo yocwaningo lwemakethe, ngaphandle kokuba ngumbiko ofunwa kakhulu wocwaningo lwemakethe ohlinzeka ngokuqinile.

Imininingwane Yokuxhumana:

Ithimba Lokuthuthukiswa Kwebhizinisi Lomhlaba Wonke - Market.us

Ikheli: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Ucingo: +1 718 618 4351 (International), Ucingo: +91 78878 22626 (Asia)

Email: [i-imeyili ivikelwe]